Claus Lindbjerg Andersen (@clauslindbjerg) 's Twitter Profile
Claus Lindbjerg Andersen

@clauslindbjerg

Professor, Depart. of Molecular Medicine (MOMA), Aarhus University Hospital and @AarhusUni.
Research focus: colorectal cancer, ctDNA, genomics, gene expression

ID: 1089153765524017152

linkhttps://moma.dk/colon-cancer calendar_today26-01-2019 13:31:08

173 Tweet

273 Followers

55 Following

Annals of Oncology (@annals_oncology) 's Twitter Profile Photo

The clinical utility of post-operative ctDNA detection using dPCR was investigated in a nationwide Danish 🇩🇰cohort of 851 patients with stage II/III colorectal cancer. Results are reported #openaccess 👇 annalsofoncology.org/article/S0923-… Claus Lindbjerg Andersen Tenna Vesterman Henriksen Dept. of Molecular Medicine 2/2

Claus Lindbjerg Andersen (@clauslindbjerg) 's Twitter Profile Photo

Shifting Recurrence Patterns May Warrant Risk-Stratified Surveillance for Colorectal Cancer insideprecisionmedicine.com/topics/oncolog… via @clinicalomics A new letter piece by Laura Cowen on our recent paper in JAMA Oncology jamanetwork.com/journals/jamao…

Dept. of Molecular Medicine (@moma_dk) 's Twitter Profile Photo

BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt. Blodprøver kan være et redskab til prioritering af operationskapacitet på kræftområdet. linkedin.com/posts/aarhus-u… 📷Jens Løgstrup

BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING

Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt. 
Blodprøver  kan være et redskab til prioritering af operationskapacitet på kræftområdet.

linkedin.com/posts/aarhus-u…
📷Jens Løgstrup
ctDNA_DK (@ctdnadk) 's Twitter Profile Photo

We wish you all a Merry Christmas and Happy New Year! 🎄 Thank you for the amazing collaboration! We look forward to more national research in ctDNA guided cancer treatment in 2024 #ctDNA #CancerResearch Claus Lindbjerg Andersen | Lars Dyrskjøt DCCC | Kræftens Bekæmpelse

We wish you all a Merry Christmas and Happy New Year! 🎄

Thank you for the amazing collaboration! We look forward to more national research in ctDNA guided cancer treatment in 2024

#ctDNA #CancerResearch 

<a href="/ClausLindbjerg/">Claus Lindbjerg Andersen</a>  | <a href="/LDyrskjot/">Lars Dyrskjøt</a> 
<a href="/DCCCcancer/">DCCC</a> | <a href="/cancer_dk/">Kræftens Bekæmpelse</a>
DCCC (@dccccancer) 's Twitter Profile Photo

Vi har givet tilsagn til 6 ansøgere, der søgte vores ekstraordinære puljemidler målrettet forskning i bedre og mere målrettet kræftopfølgning. Læs hvem der kom gennem nåleøjet: dccc.dk/nyheder/opfolg… -tak til alle ansøgere! #Samarbejdeomkræft Claus Lindbjerg Andersen Peter Christensen

Vi har givet tilsagn til 6 ansøgere, der søgte vores ekstraordinære puljemidler målrettet forskning i bedre og mere målrettet kræftopfølgning. Læs hvem der kom gennem nåleøjet: dccc.dk/nyheder/opfolg… -tak til alle ansøgere! #Samarbejdeomkræft <a href="/ClausLindbjerg/">Claus Lindbjerg Andersen</a> <a href="/AUHcolorectal/">Peter Christensen</a>
CNAPS 2024 (@cnaps2024) 's Twitter Profile Photo

The Scientific Programme Committee has decided on the best submitted abstracts for #cnaps2024 and allocated them to the programme! Take a look and do not forget to register at the regular rate until January 31st, 2024, 23:59 CET to join us in Graz! wma.eventsair.com/13th-internati…

Jesper Nors (@jespernors) 's Twitter Profile Photo

🚨 The risk of colorectal cancer recurrens has decreased! 🚨 📣 Now out in JAMA Oncology A nationwide cohort study using health-data registries. Thanks to CONNECT - Center for Clinical and Genomic Data and all our collaborators at Department of Clinical Epidemiology, Aarhus, AUHsurgery, @RandersHospital, and @HorsensHospital.

Jesper Nors (@jespernors) 's Twitter Profile Photo

🚨 New paper out in International Journal of Cancer 🚨 📝 Incidence of Late Recurrence in CRC 🚻 8,883 UICC stage I-III patients (2004-2013) 📉 5-10 year CIF was low and decreasing ⁉️ No support for prolonged surveillance 🏥 Dept. of Molecular Medicine @AuHsurgery ⁦Department of Clinical Epidemiology, Aarhus⁩ onlinelibrary.wiley.com/doi/10.1002/ij…

ctDNA_DK (@ctdnadk) 's Twitter Profile Photo

New paper published in International Journal of Cancer addressing the selection of mutations to be used as ctDNA markers 🧬📃 Find the article here: onlinelibrary.wiley.com/doi/10.1002/ij… #ctDNA #CancerResearch Dept. of Molecular Medicine

Dan Landau (@landau_lab) 's Twitter Profile Photo

Together with our large network, we applied MRD-EDGE to CRC (Claus Lindbjerg Andersen), NSCLC (nasser altorki) and BRCA (Samuel Aparicio ), including data sequenced at different centers, with outstanding performance in Neo-adjuvant and post-adjuvant predictions

Together with our large network, we applied MRD-EDGE to CRC (<a href="/ClausLindbjerg/">Claus Lindbjerg Andersen</a>), NSCLC (<a href="/AltorkiNasser/">nasser altorki</a>) and BRCA (<a href="/sajraparicio/">Samuel Aparicio</a> ), including data sequenced at different centers, with outstanding performance in Neo-adjuvant and post-adjuvant predictions
Adam Widman (@adamjwidman) 's Twitter Profile Photo

This was originally submitted in 12/2021. Thanks to collabs and coauthors for investing in this project and sticking with us. NRLlab and @clauslindbjerg were tremendous leaders. Amazing contributions from @notsojunkdna Michael Postow Marcin Imieliński and many others

Jesper Nors (@jespernors) 's Twitter Profile Photo

🚨 New paper out in The Lancet Reg Health-Europe 📝 Risk of Recurrence in early-onset vs. late-onset CRC 📉 Decreasing rates of recurrence from 2004 to 2019 ⁉️ Continued focus on early diagnosis 🧑‍🧒‍🧒 Claus Lindbjerg Andersen Rune Erichsen @SunesenKG thelancet.com/journals/lanep…